Accessory Pathways

Accessory Pathways – SAQ & EMQ Series

Clinical Scenario:
A 20-year-old male presents to the Emergency Department after collapsing and striking his head during a football match. He experienced brief loss of consciousness and is now alert but confused. Witnesses report he had palpitations immediately before the fall. He denies chest pain. Neurological exam is normal. A non-contrast head CT reveals a mild cerebral contusion.An ECG is performed on arrival, see below
Typically occurs in adolescents or young adults. Commonly presents with palpitations, syncope during exertion, or sudden collapse without prodrome.
1. Syncope during exertion
2. Family history of sudden cardiac death
3. History of rapid palpitations or documented arrhythmia
Antegrade conduction through AV node and retrograde via accessory pathway, forming a reentrant loop.
They can facilitate conduction through the accessory pathway, potentially causing ventricular fibrillation.
1. Short anterograde ERP (<250ms)
2. Multiple accessory pathways
3. Inducible AF with rapid ventricular response
Vagal maneuvers followed by adenosine if ineffective.
Catheter ablation is curative and first-line.
Pathway that conducts only retrogradely and is not visible on resting ECG.
The accessory pathway does not conduct in every beat; it may suggest a longer ERP and potentially lower risk.
1. Hypertrophic cardiomyopathy
2. Long QT syndrome
3. WPW or other accessory pathway disorders
Short PR interval, delta wave, and widened QRS complex.
IV procainamide or ibutilide under monitoring.
Electrophysiology study (EPS).
Asymptomatic patients with long accessory pathway ERP and no arrhythmias.
Estimated at 0.1–0.45% per year but varies by pathway properties.
Pilots, military personnel, professional athletes, or other safety-sensitive roles.
May shorten refractory period and unmask conduction; used during EP testing.
Early repolarization and bundle branch block.
Palpitations, chest discomfort, dizziness, or syncope.
Less than 5% in experienced centers.
Differentials:
1. Ventricular tachycardia (VT)
2. Antidromic AVRT via accessory pathway
3. SVT with aberrancy
Management:
- Assess stability: If unstable, perform synchronized cardioversion
- If stable and WPW suspected, avoid AV nodal blockers
- Consider procainamide IV if available
- Urgent electrophysiology referral if not already initiated
Sources: Braunwald’s, UpToDate, Clinical Electrophysiology
Catheter ablation is the treatment of choice with curative intent. Indications include symptomatic patients, high-risk features on EP testing, and professions where syncope poses risk.
Sources: ESC Guidelines, Braunwald’s
An anterograde ERP ≤250 ms is associated with risk of rapid ventricular response during AF and potential progression to VF. Longer ERP implies lower risk.
Sources: JACC EP, Braunwald’s
1. Restrict from competitive sports pending EP study
2. Outpatient electrophysiology referral
3. Educate about arrhythmia symptoms and warning signs
4. Consider Holter monitoring if pathway is intermittent
Sources: Ferri’s, ESC Guidelines, UpToDate

Complete and Continue